Search Results
Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia
Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia
Targeted therapy for elderly patients with Philadelphia-positive acute lymphocytic leukaemia
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
Philadelphia Chromosome Positive Acute Leukemia
Dr. Levis on a Phase II Trial Examining Quizartinib in AML
Philadelphia chromosome positive acute lymphoblastic leukemia from EHA 2014
Talking Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
The issue of relapse in Philadelphia chromosome-positive ALL patients and how to combat this
Robin Clark, PhD - Battling Philadelphia Positive Acute Lymphoblastic Leukemia (Part 1)
Nilotinib Benefits Relapsed Patients With CML After Treatment Discontinuation
The latest in Philadelphia chromosome-positive ALL (Ph+ ALL)
